Prospective study of evaluating the incidence and clinical outcomes of bioprosthetic aortic-valve thrombosis

Prospective study of evaluating the incidence and clinical outcomes of bioprosthetic aortic-valve thrombosis - The incidence and clinical outcomes of bioprosthetic aortic-valve thrombosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023940

Enrollment

300

Registered

2016-09-05

Start date

2016-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Presence of transcatheter or surgical bioprosthetic aortic valve implanted at least 48 hours prior to enrollment 2) Written informed consent is taken

Exclusion criteria

Exclusion criteria: 1) Reduced renal function (estimated glomerular filtration rate of <30 mL/[min1.73 m2] 2) Known allergy to iodinated contrast agents

Design outcomes

Primary

Measure	Time frame
Frequency of patients with bioprosthetic aortic-valve thrombosis	—

Secondary

Measure	Time frame
Frequency of valve functional abnormalities in patients with bioprosthetic aortic-valve thrombosis	—

Countries

Japan

Contacts

Public ContactRyo Yanagisawa

Keio University School of Medicine Cardiology

ryoyanagi0217@gmail.com03-3353-1211

Outcome results